| Instil Bio, Inc. (TIL) | 6.93% | $549.71M | N/A | N/A | N/A |
| Sangamo Therapeutics, Inc. (SGMO) | 1.62% | $176.65M | -94.79% | -622.75% | 6.06 |
| Foghorn Therapeutics, Inc. (FHTX) | 1.55% | $537.79M | 23.02% | 88.39% | 1.49 |
| Aldeyra Therapeutics, Inc. (ALDX) | 1.47% | $358.31M | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE) | 1.42% | $373.15M | N/A | 56.12% | 8.43 |
| Design Therapeutics, Inc. (DSGN) | 1.39% | $313.68M | N/A | N/A | N/A |
| CorMedix, Inc. (CRMD) | 1.34% | $388.23M | N/A | 36.75% | 253.66 |
| C4 Therapeutics, Inc. (CCCC) | 1.29% | $446.54M | 350.68% | 82.97% | 4.16 |
| Avid Bioservices, Inc. (CDMO) | 1.25% | $711.95M | 6.49% | 14.22% | 5.87 |
| Leap Therapeutics, Inc. (LPTX) | 1.21% | $104.84M | N/A | N/A | N/A |
| Vaxart, Inc. (VXRT) | 1.18% | $224.51M | 371.35% | 82.82% | 6.02 |
| XBiotech, Inc. (XBIT) | 1.16% | $215.07M | N/A | N/A | N/A |
| Xeris Biopharma Holdings, Inc. (XERS) | 1.16% | $429.12M | 26.46% | 78.15% | 2.90 |
| Neoleukin Therapeutics, Inc. (NLTX) | 1.15% | $544.90M | N/A | 11.68% | 515.01 |
| Anixa Biosciences, Inc. (ANIX) | 1.13% | $107.80M | N/A | N/A | N/A |
| Replimune Group, Inc. (REPL) | 1.11% | $760.42M | N/A | N/A | N/A |
| Seres Therapeutics, Inc. (MCRB) | 1.09% | $152.26M | -100.00% | N/A | 671.28 |
| Immunome, Inc. (IMNM) | 1.09% | $959.07M | -44.55% | 71.53% | 41.70 |
| Black Diamond Therapeutics, Inc. (BDTX) | 1.08% | $349.77M | N/A | N/A | N/A |
| Trevi Therapeutics, Inc. (TRVI) | 1.06% | $244.63M | N/A | N/A | N/A |
| Adaptimmune Therapeutics Plc (ADAP) | 1.06% | $283.88M | 2,394.41% | 97.86% | 0.61 |
| Akoya Biosciences, Inc. (AKYA) | 1.06% | $145.53M | -1.52% | 57.79% | 1.66 |
| uniQure NV (QURE) | 1.04% | $275.63M | 359.37% | 8.94% | 8.22 |
| Altimmune, Inc. (ALT) | 1.04% | $560.04M | -16.67% | -1,120.00% | 754.43 |
| Elutia, Inc. (AZYO) | 1.04% | $127.91M | -38.90% | 44.49% | 5.58 |
| Solid Biosciences, Inc. (SLDB) | 1.04% | $306.06M | N/A | N/A | N/A |
| Galectin Therapeutics, Inc. (GALT) | 1.04% | $178.74M | N/A | N/A | N/A |
| Spyre Therapeutics, Inc. (AGLE) | 1.03% | $1.50B | -100.00% | N/A | N/A |
| BioAtla, Inc. (BCAB) | 1.02% | $87.49M | N/A | N/A | N/A |
| Graphite Bio, Inc. (GRPH) | 1.01% | $564.99M | N/A | N/A | N/A |
| Nautilus Biotechnology, Inc. (NAUT) | 1.00% | $363.69M | N/A | N/A | N/A |
| Compass Pathways Plc (CMPS) | 0.98% | $495.81M | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV) | 0.98% | $33.61M | N/A | N/A | N/A |
| Gain Therapeutics, Inc. (GANX) | 0.96% | $37.41M | N/A | N/A | N/A |
| iTeos Therapeutics, Inc. (ITOS) | 0.96% | $609.91M | N/A | 99.12% | 0.67 |
| Poseida Therapeutics, Inc. (PSTX) | 0.94% | $298.20M | 29.78% | 94.81% | 1.46 |
| Precision BioSciences, Inc. (DTIL) | 0.93% | $74.51M | 152.15% | 97.23% | -0.28 |
| Humacyte, Inc. (HUMA) | 0.92% | $673.14M | N/A | N/A | N/A |
| OncoCyte Corp. (OCX) | 0.92% | $41.17M | -77.54% | -221.63% | 31.65 |
| Fate Therapeutics, Inc. (FATE) | 0.91% | $457.79M | 625.83% | 30.29% | 14.69 |
| Aadi Bioscience, Inc. (AADI) | 0.90% | $44.31M | -0.37% | 87.41% | -1.36 |
| AVROBIO, Inc. (AVRO) | 0.90% | $265.07M | N/A | N/A | N/A |
| Quince Therapeutics, Inc. (CRTX) | 0.89% | $31.81M | N/A | N/A | N/A |
| Nkarta, Inc. (NKTX) | 0.88% | $402.89M | N/A | N/A | N/A |
| Jasper Therapeutics, Inc. (JSPR) | 0.87% | $343.65M | N/A | N/A | N/A |
| Kodiak Sciences, Inc. (KOD) | 0.87% | $142.59M | N/A | N/A | N/A |
| Eliem Therapeutics, Inc. (ELYM) | 0.86% | $567.33M | N/A | N/A | N/A |
| Stoke Therapeutics, Inc. (STOK) | 0.86% | $761.81M | N/A | 77.02% | 31.48 |
| AlloVir, Inc. (ALVR) | 0.86% | $85.30M | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR) | 0.86% | $68.65M | 11.94% | 49.70% | 1.39 |
| Carisma Therapeutics, Inc. (SESN) | 0.85% | $42.38M | 158.34% | 97.23% | 1.28 |
| Spero Therapeutics, Inc. (SPRO) | 0.85% | $74.05M | 663.58% | 99.97% | 0.11 |
| Compugen Ltd. (CGEN) | 0.85% | $176.39M | N/A | 76.84% | 1.43 |
| Nuvation Bio, Inc. (NUVB) | 0.85% | $757.15M | N/A | -10.87% | 297.62 |
| Seer, Inc. (California) (SEER) | 0.84% | $96.98M | -23.35% | 7.45% | -10.21 |
| Enzo Biochem, Inc. (ENZ) | 0.84% | $57.12M | -50.20% | 46.53% | -0.05 |
| Mersana Therapeutics, Inc. (MRSN) | 0.84% | $258.84M | -78.48% | 82.42% | 3.86 |
| Ikena Oncology, Inc. (IKNA) | 0.83% | $81.56M | -100.00% | N/A | -30.75 |
| SAB Biotherapeutics, Inc. (SABS) | 0.83% | $25.75M | 207.70% | -288.39% | -1.18 |
| VistaGen Therapeutics, Inc. (VTGN) | 0.83% | $89.01M | -52.70% | -79.76% | 0.13 |
| MeiraGTx Holdings Plc (MGTX) | 0.82% | $328.95M | -92.03% | -1,042.55% | 31.84 |
| ProKidney Corp. (DNAC) | 0.81% | $301.26M | N/A | N/A | N/A |
| Vigil Neuroscience, Inc. (VIGL) | 0.81% | $145.51M | N/A | N/A | N/A |
| CARA Therapeutics, Inc. (CARA) | 0.80% | $14.40M | -85.71% | 92.23% | 0.42 |
| InflaRx NV (IFRX) | 0.79% | $84.20M | N/A | -5,376.69% | 202.13 |
| Invivyd, Inc. (ADGI) | 0.79% | $137.36M | N/A | 73.41% | -7.02 |
| LAVA Therapeutics NV (LVTX) | 0.78% | $45.22M | -100.00% | N/A | -4.37 |
| Greenwich LifeSciences, Inc. (GLSI) | 0.78% | $196.25M | N/A | N/A | N/A |
| Ventyx Biosciences, Inc. (VTYX) | 0.77% | $161.83M | N/A | N/A | N/A |
| Spruce Biosciences, Inc. (SPRB) | 0.77% | $19.22M | -25.64% | 99.25% | -4.67 |
| Co-Diagnostics, Inc. (CODX) | 0.75% | $41.80M | -18.56% | -241.70% | -0.72 |
| Verastem, Inc. (VSTM) | 0.75% | $113.08M | N/A | 99.94% | 5.97 |
| Kezar Life Sciences, Inc. (KZR) | 0.75% | $41.59M | N/A | N/A | -14.69 |
| Passage Bio, Inc. (PASG) | 0.75% | $49.83M | N/A | N/A | N/A |
| Larimar Therapeutics, Inc. (LRMR) | 0.75% | $459.41M | N/A | N/A | N/A |
| TScan Therapeutics, Inc. (TCRX) | 0.75% | $279.52M | -82.97% | -108.21% | 37.45 |
| Vor Biopharma, Inc. (VOR) | 0.75% | $71.82M | N/A | N/A | N/A |
| Shattuck Labs, Inc. (STTK) | 0.74% | $181.84M | 704.50% | 40.21% | 22.92 |
| MiNK Therapeutics, Inc. (INKT) | 0.72% | $30.66M | N/A | N/A | N/A |
| HCW Biologics Inc. (HCWB) | 0.71% | $23.07M | -0.63% | 8.16% | 8.50 |
| Reneo Pharmaceuticals, Inc. (RPHM) | 0.68% | $43.79M | N/A | N/A | N/A |
| ImmuCell Corp. (ICCC) | 0.68% | $28.43M | 54.92% | 22.48% | 2.26 |
| 23andMe Holding Co. (ME) | 0.68% | $115.43M | -33.60% | 36.44% | 0.49 |
| Taysha Gene Therapies, Inc. (TSHA) | 0.66% | $469.32M | -53.57% | 73.02% | 31.54 |
| HOOKIPA Pharma, Inc. (HOOK) | 0.66% | $48.18M | -51.85% | 44.65% | 0.04 |
| Voyager Therapeutics, Inc. (VYGR) | 0.65% | $340.83M | 509.48% | 95.29% | 0.92 |
| Gritstone bio, Inc. (GRTS) | 0.65% | $65.03M | -85.75% | -2,707.02% | 270.26 |
| INmune Bio, Inc. (INMB) | 0.62% | $108.01M | -100.00% | N/A | 1,701.80 |
| Prelude Therapeutics, Inc. (PRLD) | 0.61% | $116.82M | N/A | N/A | N/A |
| X4 Pharmaceuticals, Inc. (XFOR) | 0.60% | $119.63M | N/A | 17.94% | 46.07 |
| Curis, Inc. (CRIS) | 0.58% | $32.65M | 15.89% | 97.09% | 5.29 |
| Precigen, Inc. (PGEN) | 0.58% | $302.46M | -59.42% | -209.90% | 87.84 |
| Affimed NV (AFMD) | 0.58% | $60.91M | -89.04% | N/A | 21.30 |
| BioVie, Inc. (BIVI) | 0.57% | $19.33M | N/A | N/A | N/A |
| ImmunoPrecise Antibodies Ltd. (IPA) | 0.56% | $18.05M | 16.84% | 37.05% | 2.22 |
| IO Biotech, Inc. (IOBT) | 0.53% | $49.48M | N/A | N/A | N/A |
| Coeptis Therapeutics Holdings, Inc. (BHSE) | 0.51% | $7.48M | N/A | N/A | N/A |
| BioXcel Therapeutics, Inc. (BTAI) | 0.51% | $27.71M | 141.58% | 87.41% | 41.15 |
| Heron Therapeutics, Inc. (HRTX) | 0.49% | $283.62M | 13.42% | 70.80% | 4.73 |
| Bionano Genomics, Inc. (BNGO) | 0.49% | $37.00M | -10.29% | 33.26% | 1.19 |
| Rani Therapeutics Holdings, Inc. (RANI) | 0.48% | $69.42M | N/A | N/A | N/A |
| Century Therapeutics, Inc. (IPSC) | 0.47% | $135.55M | 678.79% | -349.03% | 33.94 |
| PepGen Inc. (PEPG) | 0.47% | $308.95M | N/A | N/A | N/A |
| Omega Therapeutics, Inc. (OMGA) | 0.46% | $73.36M | 181.16% | 71.27% | 30.87 |
| Aspira Women's Health, Inc. (AWH) | 0.44% | $13.67M | -2.73% | 58.65% | 2.25 |
| Cyclo Therapeutics, Inc. (CYTH) | 0.42% | $18.56M | 5.11% | -656.37% | 33.77 |
| Nascent Biotech, Inc. (NBIO) | 0.39% | $7.19M | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE) | 0.37% | $28.65M | 92.33% | 67.42% | 5.24 |
| Agenus, Inc. (AGEN) | 0.36% | $135.04M | -7.06% | 85.21% | 4.33 |
| Renovaro, Inc. (ENOB) | 0.35% | $96.62M | N/A | N/A | N/A |
| Syros Pharmaceuticals, Inc. (SYRS) | 0.30% | $52.12M | -100.00% | N/A | 44.44 |
| Cognition Therapeutics, Inc. (CGTX) | 0.27% | $24.08M | N/A | N/A | N/A |
| Athira Pharma, Inc. (ATHA) | 0.19% | $20.30M | N/A | N/A | N/A |
| Vaxxinity, Inc. (VAXX) | 0.09% | $2.54M | N/A | N/A | N/A |
| eFFECTOR Therapeutics, Inc. (EFTR) | 0.03% | $0.22M | N/A | N/A | N/A |